RVMD Jun 2024 45.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:51AM EDT. Market open.
| Previous close | 2.2000 |
| Open | 2.2000 |
| Bid | 0.1000 |
| Ask | 1.0000 |
| Strike | 45.00 |
| Expiry date | 2024-06-21 |
| Day's range | 2.2000 - 2.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 416 |
Simply Wall St.Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable
Key Insights Revolution Medicines will host its Annual General Meeting on 20th of June Total pay for CEO Mark Goldsmith...
GlobeNewswireRevolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. Details of the company’s participation are as follows: Goldman Sachs 45th Annual Gl
GuruFocus.comRevolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...
Insights into RVMD's Financial Health and Future Directions
© 2024 Yahoo. All rights reserved.